1.GENERAL INFORMATION


Please read the instructions below carefully for details on the submission of manuscripts.


Avoiding Plagiarism

The article submitted through a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously-published work.


2. ETHICAL GUIDELINES

Authorship and Acknowledgements

Authors those submitting a paper do so on the understanding that the manuscript have been read and approved by all authors and that all authors agree to the submission of the manuscript to the Journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper and ALL must have critically reviewed its content and have approved the final version submitted for publication. Participation solely in the acquisition of funding or the collection of data does not justify authorship.

IRJCM adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.


Number of Authors for Authorship

Up to 8 authors are accepted without need for justification. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

Acknowledgements: Under acknowledgements please specify contributors to the article other than the authors accredited. Acknowledge only persons who have made substantive contributions to the study. Authors are responsible for obtaining written permission from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions.


3.MANUSCRIPT SUBMISSION PROCEDURE

Manuscript Files Accepted

Manuscripts should be prepared as Word (.doc) or Rich Text Format (.rft) files (not write-protected) plus separate figure files. GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only high-resolution TIF or EPS files are suitable for printing. The text file must contain the entire manuscript including title page, summary, text, references, tables, and figure legends, but no embedded figures. In the text file, please reference figures as for instance 'Figure 1', 'Figure 2' etc to match the tag name you choose for the individual figure files.

Manuscripts should be formatted as described in the Author Guidelines below. Please note that any manuscripts uploaded as Word 2007 (.docx) will be unassigned. Please save any .docx file as .doc before uploading.

Blinded Review

All manuscripts submitted to International Journal of Preventive and Public Health Sciences will be reviewed by at least two experts in the field. The names of the reviewers will not be disclosed to the author submitting a paper.


4.MANUSCRIPT FORMAT AND STRUCTURE

Manuscript Requirements By Type

The International Research Journal of Clinical Medicine welcomes authors to submit the following types of manuscripts:


Original Research Articles: Original researches articles are papers that describe significant clinical or basic research and must provide adequate detail so that the experiment can be critically evaluated. Manuscripts submitted as original research articles have a limit of 4000 words (excluding title page and references), and they should comprise of the following sections:

(1) title page; (2) structured abstract, no more than 300 words; (3) keywords; (4) introduction;(5) materials and methods; (6) results; (7) discussion; (8) conclusion; (9) acknowledgment; (10) references; and (11) tables and figures.

Reviews: Review articles are papers that collect and analyze the research findings on a particular basic or clinical topic. Review article should take a broad view of the field and use evidence-based systematic approaches. Review papers should be should be limited to 3000 words (excluding title page and references), and they should contain the following sections: (1) title page; (2) unstructured abstract, no more than 250 words; (3) keywords; (4) introduction; (5) main body; (6) conclusion; (7) acknowledgment; (8) references; and (9) tables and figures.

Case Reports: Case Reports and case series are papers that present one or more well-documented unique clinical cases which provide clinically valuable information. Case reports and case series should not exceed 3000 words, and they should include the following sections: (1) title page; (2) unstructured abstract, no more than 200 words; (3) keywords; (4) introduction; (5) case description and results; (5) discussion; (6) conclusion; (7) acknowledgment; (8) references; and (9) tables and figures.

Case Reports(Pictorial):-Template should be used to submit this form of article. It is available at http://www.irjcm.com/downloadsforms.html

Brief description of upto 400 words should be written which should cover the brief about that particular case. Points to ponder are important points that should be kept in mind or some striking features of case. References should be written in Vancouver style (5 References Maximum). Maximum 5 images should be added. The images should not be added to this document. They should be attached to mail along with this template. Only the figure legends/captions should be mentioned.

Short communication :Short communications of 1-2 (3-6 double spaced) pages will be acceptable and need not follow the usual division into Materials and Methods etc. but should have an abstract. Short communications will not be subjected. No longer than 2000 words. Abstract within 150 words

Letters to the Editor: Letters are the papers which offer constructive criticism on articles published in the Journal. They should discuss articles published in the last issue of the journal, and they must be submitted within three months of the article’s publication date. Letters should not exceed 500 words.


Manuscript Format and Structure

International Research Journal of Clinical Medicine accepts manuscripts which are prepared in accordance with the “Uniform requirements for Manuscripts submitted to Biomedical Journal” developed by the International Committee of Medical Journal Editors(ICMJE).Manuscripts must be in English and should be written in a clear, concise, and direct style. They should be typed as a Microsoft Word document in double space on the A-4 size page set up with margins of at least 1 inch (25 mm). All pages should be numbered consecutively beginning with the title page. Tables and figures should not be embedded in the body of the text, but they should be placed after the references. Each of the following sections should begin on a separate page:


Title page: The title page should carry the following items: (1) the complete title of the paper; (2) the full names of the authors, with the highest academic degree; (3) the academic affiliation of the authors; (4) a short title of no more than 40 characters; (5) the full name, postal address, telephone number, and email address for the corresponding author.

The title must be concise, informative and contain the major key words. Please avoid abbreviations in the title.

Abstract and Keywords: The abstract should provide an accurate summary of the study. For original Research Articles, the abstract should be structured and organized into the following headings: Introduction, Purpose, Methods, Results and Conclusion. The abstract should not contain abbreviations, table, or references. Five to ten key words should be provided below the abstract in alphabetical order. Use terms from the Medical Subject Headings (MeSH) list of Index Medicus when possible (available at http://www.nlm.nih.gov/mesh/meshhome.html).

Introduction: : This should summarize the rationale and provide a background for the study. The specific purpose of the study must be clearly stated at the final paragraph of the introduction.

Materials and Methods:This section must describe the methods used in the research in sufficient detail so that other researchers would be able to fully reproduce the study. If established methods are used, authors should give reference and present the method only briefly. Statistical method should be described in adequate detail. When the materials or devices are first identified, specific proprietary name, manufacturer, and the location of manufacturer (city and country) should be given in parenthesis.

Results: It should be presented in a logical sequence in the text, tables, and illustrations. The contents that appear in the tables should not be repeated in the text. Authors should provide exact p-values where they report statistically significant differences.

Discussion: It should emphasize the new and important findings of the research and relate the present findings to those of other relevant studies conducted in the field. In addition, the discussion should provide implications of the findings and describe the strengths and limitations of the study.

Conclusion: Conclusion must be based on the data presented in the study, and it should be closely linked to the objectives of the study. Unqualified statements and conclusions not adequately supported by data must be avoided.


• Ethical Approvals

Experimentation involving human subjects will only be published if such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version, 2008) and the additional requirements, if any, of the country where the research has been carried out. Manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject and according to the above mentioned principles. A statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included. Editor reserve the right to reject papers if there are doubts as to whether appropriate procedures have been used.

When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.


• Clinical Trials

IRJCM encourages authors submitting manuscripts reporting from a clinical trial to register the trials in any of the following free, public clinical trials

registries: www.clinicaltrials.gov ,http://clinicaltrials.ifpma.org/clinicaltrials, http://isrctn.org.

The clinical trial registration number and name of the trial register will then be published with the paper.


• Conflict of Interest and Source of Funding

IRJCM requires that sources of institutional, private and corporate financial support for the work within the manuscript be fully acknowledged, and any potential conflicts of interest noted. Suppliers of materials should be named and their location (town, state/county, country) included. Information concerning conflict of interest and sources of funding should be included under Acknowledgements.


• Appeal of Decision

The decision on a paper is final and cannot be appealed.


• Photographs of People

The IRJCM follows current HIPAA guidelines for the protection of patient/subject privacy. If an individual pictured in a digital image or photograph can be identified, his or her permission is required to publish the image. The corresponding author may submit a letter signed by the patient authorizing the International Journal of Preventive and Public Health Sciences to publish the image/photo. Or, a form provided by the International Journal of Preventive and Public Health Sciences (available on download page) may be downloaded for your use. The approval must be received by the Editorial Office prior to final acceptance of the manuscript for publication. Otherwise, the image/photo must be altered such that the individual cannot be identified (black bars over eyes, tattoos, scars, etc.). The IRJCM will not publish patient photographs that will in any way allow the patient to be identified, unless the patient has given their express consent.


• Copyright Assignment

If your paper is accepted, the author are requested to send duly signed copyright transfer form by all authors.

More details on these and other reporting guidelines are also available on the website of US National Library of Medicine.


Randomized controlled trials:All randomized controlled trials submitted for publication in Journal of IRJCM should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Submitted manuscripts that do not include this flow chart, where appropriate, will be rejected without entering the review process. Please refer to the CONSORT statement website at www.consort-statement.org for more information. International Research Journal of Clinical Medicine has adopted the proposal from the International Committee of Medical Journal Editors (ICMJE) which require, as a condition of consideration for publication of clinical trials, registration in a public trials registry. Trials must register at or before the onset of patient enrollment The clinical trial registration number should be included at the end of the abstract of the article. For this purpose, a clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Further information can be found at http://www.icmje.org

Disclosure of Clinical Trial Results: In line with the position of the International Committee of Medical Journal Editors , the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (eg, investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.

Patient consent: Studies on patients or volunteers require ethics committee approval and informed consent which should be documented in your paper. Patients have a right to privacy. Therefore identifying information, including patients images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, IRJCM must be made aware of all such conditions. Written consents must be provided to IRJCM on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.

Acknowledgement: Acknowledgments may be made to individuals who contributed specify contributors to the article other than the authors accredited. Acknowledgments should also specify the source of any funding for the study.

References: References must be listed at the end of the paper and numbered consecutively in the order in which they are first mentioned in the text. All references must be cited in text or tables by numeric in superscript. Authors are encouraged to use only English references. In addition, authors are responsible for the accuracy of the references and for their correct citation.


International Research Journal of Clinical Medicine (IRJCM) follows Uniform Requirements style for references offered by International Committee of Medical Journal Editors. Examples can be found at: www.nlm.nih.gov/bsd/uniform_requirements.html

Examples as follows: Journal Articles:

Liu BY, Lo EC, Chu CH, Lin HC. Randomized trial on fluorides and sealants for fissure caries prevention. J Dent Res. 2012 Aug;91(8):753-8.


More than six authors:

Papas AS, Vollmer WM, Gullion CM, Bader J, Laws R, Fellows J, et al. Efficacy of chlorhexidine varnish for the prevention of adult caries: a randomized trial. J Dent Res. 2012 Feb;91(2):150-5.


Books: Personal author(s):

Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.


Author(s) and editor(s):

Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.


Chapter in a book:

Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.


Tables: : Each table should be typed on a separate sheet of paper and headed by a brief descriptive title. Tables should be numbered consecutively in Arabic numbers in the order of their citation in the text. Authors should list explanations, including abbreviations, as footnotes, not in the heading.

Figures: Figures should be import in the text each on a separate page, and also they should be supplied separately in jpg, TIFF or other graphics file. Figures should be numbered consecutively according to the order in which they have been cited in the text. Each figure should have a brief caption that adequately describes the figure. If a figure has previously been published, written permission from the copyright holder must be provided.

  • Permissions: If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers.
  • Acceptance Policy:When the author sends us the manuscripts initially, the journal team would send confirmation mail for payment. Once the authors agree to pay the money, then only review process will be commenced. Upon acceptance of a manuscript for publication, acceptance letter will be forwarded to you. After that once the article is accepted and when the acceptance letter is sent to Authors, the authors cannot back out with their article. If author wants to withdraw the article after acceptance letter has been send the author has to pay the peer review charges. The peer review charges would be decided by Editorial team as it would differ with each article and reviewers. If the authors don’t pay the peer review charges the author’s article will be kept with journal database and it will be hence forth property of journal. Then authors would have no rights with that particular article and journal hold rights to take action against author or do anything with that article.
  • Proof Corrections: The corresponding author will receive an email containing a designed article. Hence a working email address must therefore be provided for the corresponding author. The proof will be in PDF (portable document format) format. This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Proofs must be returned within three days of receipt. Please note that the author is responsible for all statements made in his work, including changes made by the copy editor.